Title Inactivation methods for experimental Nipah virus infection /
Authors Widerspick, Lina ; Vázquez, Cecilia Alejandra ; Niemetz, Linda ; Heung, Michelle ; Olal, Catherine ; Bencsik, András ; Henkel, Christoph ; Pfister, Anneke ; Brunetti, Jesús Emanuel ; Kučinskaitė-Kodzė, Indrė ; Lawrence, Philip ; Fontela, César Muñoz ; Diederich, Sandra ; Escudero-Pérez, Beatriz
DOI 10.3390/v14051052
Full Text Download
Is Part of Viruses.. Basel : MDPI. 2022, vol. 14, no. 5, art. no. 1052, p. [1-14].. eISSN 1999-4915
Keywords [eng] BSL-4 ; immunofluorescence ; inactivation ; Nipah virus ; plaque assay ; RT-qPCR ; syncytia
Abstract [eng] Nipah virus (NiV) is an emerging zoonotic paramyxovirus that causes severe disease in humans and livestock. Due to its high pathogenicity in humans and the lack of available vaccines and therapeutics, NiV needs to be handled in biosafety level 4 (BSL-4) laboratories. Safe inactivation of samples containing NiV is thus necessary to allow further processing in lower containment areas. To date, there is only limited information available on NiV inactivation methods validated by BSL-4 facilities that can be used as a reference. Here, we compare some of the most common inactivation methods in order to evaluate their efficacy at inactivating NiV in infected cells, supernatants and organs. Thus, several physical and chemical inactivation methods, and combinations thereof, were assessed. Viral replication was monitored for 3 weeks and NiV presence was assessed by RT-qPCR, plaque assay and indirect immunofluorescence. A total of nineteen methods were shown to reduce NiV infectious particles in cells, supernatants and organs to undetectable levels. Therefore, we provide a list of methods for the safe and efficient inactivation of NiV.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2022
CC license CC license description